Stockholm - Delayed Quote SEK

ProstaLund AB (publ) (PLUN.ST)

1.1700 +0.0450 (+4.00%)
At close: 5:22 PM GMT+2
Loading Chart for PLUN.ST
DELL
  • Previous Close 1.1250
  • Open 1.1950
  • Bid 1.1050 x --
  • Ask 1.1700 x --
  • Day's Range 1.1250 - 1.1950
  • 52 Week Range 0.9120 - 3.0400
  • Volume 79,806
  • Avg. Volume 105,495
  • Market Cap (intraday) 89.609M
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.

prostalund.se

8

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PLUN.ST

Performance Overview: PLUN.ST

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PLUN.ST
28.22%
OMX Stockholm 30 Index
9.56%

1-Year Return

PLUN.ST
69.97%
OMX Stockholm 30 Index
17.51%

3-Year Return

PLUN.ST
76.87%
OMX Stockholm 30 Index
16.89%

5-Year Return

PLUN.ST
17.08%
OMX Stockholm 30 Index
65.17%

Compare To: PLUN.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PLUN.ST

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    86.16M

  • Enterprise Value

    72.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.47

  • Price/Book (mrq)

    1.56

  • Enterprise Value/Revenue

    3.25

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -76.60%

  • Return on Assets (ttm)

    -13.78%

  • Return on Equity (ttm)

    -35.08%

  • Revenue (ttm)

    22.21M

  • Net Income Avi to Common (ttm)

    -17.01M

  • Diluted EPS (ttm)

    -0.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.35M

  • Total Debt/Equity (mrq)

    2.41%

  • Levered Free Cash Flow (ttm)

    -18.27M

Research Analysis: PLUN.ST

Company Insights: PLUN.ST

Research Reports: PLUN.ST

People Also Watch